?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
The Issue
Our Solutions
Biosimilars 101
Foundations
Core Principles
FDA Regulatory Tenets
Biosimilars FAQs
Future Evolution of Biosimilar Development
Approved Biosimilars
Advocacy
Our Action
Tools
News
Resources
Get Involved
Partners
Katie Quinn
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
September 14, 2017
Katie Quinn
Biosimilars Forum Opposes Current CMS Rule That Would Adversely Affect Biosimilars Development in the U.S.; Submits Comments on Appropriate Biosimilar Reimbursement Policy
News
August 19, 2017
Katie Quinn
Biosimilars Forum Applauds President Trump for Signing the FDA Reauthorization Act
News
August 3, 2017
Katie Quinn
Biosimilars Forum Applauds Senate Passage of the FDA Reauthorization Act
News
July 19, 2017
Katie Quinn
Biosimilars Forum Makes Available Xcenda Study on Budgetary Impact of Biosimilars Coding
News
July 14, 2017
Katie Quinn
Biosimilars Forum Applauds CMS Decision to Revisit Biosimilars Coding Policy
News
May 12, 2017
Katie Quinn
Biosimilars Forum Applauds Senator Roberts, Reps. Barton, Eshoo for Leadership on Medicare Policy on Biosimilar Coding
News
May 11, 2017
Katie Quinn
Biosimilars Forum Statement Regarding Newly Released EMA Information Guide on Biosimilars For Healthcare Professionals
News
May 10, 2017
Katie Quinn
Biosimilars Forum Statement Regarding Confirmation of Dr. Scott Gottlieb as Commissioner of the Food and Drug Administration
News
May 3, 2017
Katie Quinn
Biosimilars Forum Submits Comments in Response to FDA’s Draft Guidance for Industry on Interchangeability for Biosimilar Products
News
March 14, 2017
Katie Quinn
Biosimilars Forum Congratulates Seema Verma on Confirmation as Next Administrator of the Centers for Medicare and Medicaid Services
Prev page
03
04
05
06
07
Next page